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Characterization of prostate epithelial stem/progenitor cells
Stem and progenitor cells act as a regeneration system replenishing specialized cells, and also enabling the normal turnover and functional regeneration of organs in the adult organism. Stem /progenitor cells are defined by their ability to self-renew and their capacity to differentiate into specialized cell types. Toti-and pluripotent stem cells can give rise to any mature cell type, whereas multipotent stem/progenitor cells can differentiate into cells of a closely related cell family, e.g. epithelial cells.
Stem/progenitor cells responsible for tissue homeostasis of various epithelial tissues with diverse architectural design and physiology like intestine, epidermis, mammary gland or cornea have been described and characterized (Blanpain et al., 2007) .
The human prostate, an androgen-dependent walnut-sized sex accessory gland surrounding the urethra at the base of the bladder, serves a crucial function in the male reproductive tract by producing approximately 30% of seminal fluid providing nutrients and optimal ionic milieu and pH for sperm.
Prostate epithelial stem/progenitor cells (PESCs) have long been hypothesized to be present in the basal cell layer of the stratified prostate epithelium (Isaacs and Coffey, 1989) , although only in recent years several markers for their characterization and localization have been investigated. In the murine prostate the actively proliferating cells were found to be located in the distal region of the prostatic ducts, whereas in the proximal ductal region cells with stem cell features (quiescent, high proliferation potential) were concentrated (Tsujimura et al., 2002) . These cells were further characterized by high expression of the cell surface protein stem cell antigen 1 (Sca-1), coexpression of 6 integrin and the antiapoptotic factor Bcl-2, and showed a higher efficiency to generate prostatic tissue in in vivo reconstitution assays when compared with Sca-1 -cells or Sca-1 expressing cells from remaining regions of the duct . Bcl-2 is supposed to protect the PESCs from the apoptotic -4 -effects of high levels of active TGF- produced by cells in the proximal niche to maintain the PESCs in a dormant state .
High levels of 6 integrin has also been demonstrated for other stem/progenitor cells like basal keratinocytes in the epidermis and spermatogonial stem cells in the testis (Jones and Wagers, 2008 (Bhatt et al., 2003) . ABCG2-mediated efflux of androgen has been proposed to contribute to the maintenance of the PESC phenotype, which among other features is characterized by lack of androgen receptor (AR) protein (Huss et al., 2005) .
PESC function: tissue homeostatsis
The main function of the PESCs is to preserve tissue homeostasis of the gland by giving rise to differentiated specialized progeny as there are secretory and neuroendocrine cells. The prostate is an androgen-dependent organ, that reduces its size dramatically upon androgen deprivation. This is mainly caused by apoptosis of luminal cells, while basal epithelial cells stay intact. Early experiments in rodents demonstrated, that administration of androgens renewed the prostate epithelium in castrated rats. The fact that basal cells remained intact upon androgen deprivation and gave rise to fully functional luminal cells after re-administration led to the stem cell theory of prostate growth proposing androgen independent stem/progenitor cells (Isaacs and Coffey, 1989) .
Epithelial cell differentiation is a complex process governed by the expression of intrinsic genes that mediate differentiation and growth processes. Mesenchymalepithelial interactions have an instructive role during the androgen-induced development of the prostate. Freshly isolated mouse prostate epithelial cells can 3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 -6 -regenerate fully differentiated prostate tissue when combined with embryonic urogenital sinus mesenchyme and grafted in vivo (Cunha and Lung, 1978) but not when transplanted without supporting stromal cells. Stromal-epithelial interactions play also a key role in the maintenance of the adult prostatic epithelium Untergasser et al., 2005) . The local extracellular matrix, stromal growth factors and androgens are essential for functional and morphological differentiation of the prostatic epithelium (Hayward et al., 1992) . (Hudson et al., 2001 ) and prostate stem cell antigen (Tran et al., 2002) . Moreover, they still retain basal cytokeratins 5/14 and acquire luminal cytokeratins 8/18. Depending whether they differentiate into secretory or neuroendocrine cell lineages they express androgen receptors (AR) (Bonkhoff and Remberger, 1993) or Chromogranin A (CgA), neuron specific enolase (NSE) and human chorionic gonadotropin alpha (hCG) Bonkhoff et al., 1994; Rumpold et al., 2002) . (ARSRD5A2) and cytochrome P-450 17A1 (CYP17A), have been identified that correlate with a high risk for development of PCa . Interestingly, most of these predisposition genes are involved in host responses to infections or in metabolism of sex-steroid hormones.
Somatic mutations of stem/precursor cells, accumulating over a period of several decades can affect genes involved in growth regulation (p27; NKX3.1), cell signaling (PTEN), terminal differentiation (AR), DNA-protection (GSTP1) and repair (Bell and 3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 -8 - Van Zant, 2004; Reya et al., 2001 ). The frequency of somatic mutations are dramatically increased by inflammatory processes. Prostatic inflammation is a common event observed in prostate tumorigenesis and glandular atrophy (De Marzo et al., 1999) . Moreover, proliferative inflammatory atrophy (PIA) shares molecular traits with prostate intraepithelial neoplasia (PIN), that is accepted as the most likely preinvasive stage of adenocarcinoma of the prostate (Bostwick and Qian, 2004; Nelson et al., 2003) . The most frequent tumor-associated genetic event identified to date is fusion of the 5' untranslated region of the androgen-regulated gene TMPRSS2 to the oncogenic ETS transcription factor family members, ERG and ETV1 that are commonly overexpressed in PCa (Tomlins et al., 2005) .
Mutations in these genes responsible for normal prostate development, differentiation and growth regulation are thought to trigger initiation and then progression and metastasis of PCa (Isaacs et al., 1995) . As tumor cells express luminal characteristics, classically mutated luminal cells were thought to be the origin of PCa.
However, after initially successful androgen ablation therapy of the strongly androgen-dependent primary adenocarcinomas in most cases highly aggressive androgen independent tumors recur, that may express some basal cell characteristics. Therefore it is hypothesized that prostate cancer cells may be derived age, while non-stem/precursor cells are generally destined for terminal differentiation within a window of time too short for acquisition of sequential mutations that must affect both copies of a wild-type tumor suppressor (Hanahan and Weinberg, 2000) . 3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 -9 -Despite a variety of genetic and environmental factors, age is the most significant risk factor for the development of the malignancy. Within aging precursor/stem cells accumulate several mutations that lead to neoplastic transformation, when mutations affect genes involved in terminal growth arrest or differentiation (Bell and Van Zant, 2004; Reya et al., 2001) . These transformed cells give rise to transit amplifying daughter cells that in turn are not able to differentiate appropriate into columnar secretory cells and form precancerous proliferative lesions associated with chronic inflammation (PIA) (De Marzo et al., 1999; van Leenders et al., 2003) . Acquisition of further mutations and genomic instabilities in turn lead to transition of inflammatory lesions into low and high grade prostatic intraepithelial neoplasms (PIN), that are heterogeneous, non-clonal and accumulate age-dependently .
Most of these damaged transit-amplifying cells will differentiate into the intermediate/luminal phenotype that utilizes androgens and stroma-derived andromedins for proliferation, but not for terminal differentiation. These primary adenocarcinomas are strongly androgen-dependent and express luminal (PAP, PSA, AR, K8/18, as well as intermediate cell markers (PSCA, pp32) . To some lower extent transit-amplifying cells will also differentiate into intermediate/ neuroendocrine cells that express CgA, NSE, K5, and Bcl-2 and focally build subpopulations in the adenocarcinoma (Bonkhoff, 2001 ).
This primary androgen-sensitive adenocarcinomas contain predominantly intermediate /luminal phenotypes and can be effectively treated by androgen-ablation therapy. Nevertheless, many tumor patients fail this therapy and die of recurrent androgen-independent PCa (AIPC). Several pathways of selection of androgen independent tumor phenotypes by which AIPC can develop have been proposed, all of which may be operative (Craft et al., 1999; Feldman and Feldman, 2001 ). These (Feldman and Feldman, 2001) . These mechanisms are referred to in the literature (Feldman and Feldman, 2001) as the hypersensitive pathway (overexpression of the AR), the promiscuous pathway (mutations of the AR decrease its specificity), the outlaw pathway (ligand-independent AR activation) and the bypass pathway (overexpression of antiapoptotic genes, differentiation to androgen-independent neuroendocrine phenotypes). PCa will hopefully lead to new preventive and therapeutic treatments for these malignancies. 3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 -15 - 
